Patent 10792416

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-pro

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

  • IPR2025-01420IPRfiled Oct 9, 2025vs. Terumo BCT, Inc.Discretionary Denial

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (3)

Group view →

Specific litigation cases in our database that name US patent 10792416. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

As a patent attorney, I can report the following known litigation involving U.S. Patent No. 10,792,416 based on my review of available information as of April 26, 2026.

District Court Litigation

1. Haemonetics Corp. v. Terumo BCT, Inc.

  • Plaintiff: Haemonetics Corporation
  • Defendant: Terumo BCT, Inc.
  • Jurisdiction: U.S. District Court for the District of Colorado
  • Case Number: 1:25-cv-01409-RMR-SBP
  • Filing Date: May 5, 2025
  • Outcome or Current Status: The case is currently active. A scheduling order was issued on August 19, 2025. In this action, Haemonetics alleges that Terumo BCT's Rika Plasma Donation System™ infringes on nine of its patents, including the '416 patent. Haemonetics is seeking damages, including a reasonable royalty and lost profits, as well as treble damages for alleged willful infringement.

2. Haemonetics Corp. v. Fresenius Kabi USA, LLC, et al.

  • Plaintiff: Haemonetics Corporation
  • Defendants: Fresenius Kabi USA, LLC, Fenwal Inc., and Fresenius Kabi AG
  • Jurisdiction: U.S. District Court for the Northern District of Illinois
  • Case Number: 1:25-cv-08680
  • Filing Date: July 25, 2025
  • Outcome or Current Status: This case is active, with an answer and counterclaims filed as of January 2026. While not all initial filings explicitly list every patent-in-suit, related patent office proceedings indicate that this case is connected to the litigation involving the '416 patent family. Haemonetics alleges that the defendants' Aurora Xi Plasmapheresis System infringes on its patents related to optimized plasma collection.

Patent Trial and Appeal Board (PTAB) Proceedings

In addition to the district court cases, U.S. Patent No. 10,792,416 has been the subject of a challenge at the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

  • Terumo BCT, Inc. v. Haemonetics Corp.
    • Proceeding Type: Inter Partes Review (IPR)
    • Case Number: IPR2025-01420
    • Filing Date: October 9, 2025
    • Outcome or Current Status: This proceeding challenges the validity of U.S. Patent No. 10,792,416. The outcome of this IPR could impact the co-pending district court litigation.

Generated 5/13/2026, 12:22:18 AM